Skip to main content
Premium Trial:

Request an Annual Quote

Knome Providing NGS Data Interpretation Solution to LabCentral Startups for Free

NEW YORK (GenomeWeb) – Knome today announced a sponsorship agreement to offer its next-generation sequencing data analysis system to startups in LabCentral's facility for free.

LabCentral was founded in late 2013 as a shared laboratory space to help launch high-potential life sciences and biotech startups. It currently hosts 25 companies in its Cambridge, Mass.-based facility and anticipates being at full capacity in the fall, Knome said.

Companies there will be able log into Knome's KnoSys Informatics and Genomic Interpretation System, located at the company's Cambridge facility, then upload their samples, analyze them, and export results. The startups also will have access to Knome's experts for training and support.

KnoSys is for clinical and translational medicine applications and offers a scalable, production-grade, customizable system for customers who want to bring in house the analysis of their NGS data. The solution is a fully integrated system for alignment, variant calling, annotation, multisample comparison, interpretation, variant classification, report content drafting, and storage of human genome sequence data. Version 3 of KnoSys was released last month.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.